Natural killer cells in sepsis: Friends or foes?

Front Immunol. 2023 Jan 26:14:1101918. doi: 10.3389/fimmu.2023.1101918. eCollection 2023.

Abstract

Sepsis is one of the major causes of death in the hospital worldwide. The pathology of sepsis is tightly associated with dysregulation of innate immune responses. The contribution of macrophages, neutrophils, and dendritic cells to sepsis is well documented, whereas the role of natural killer (NK) cells, which are critical innate lymphoid lineage cells, remains unclear. In some studies, the activation of NK cells has been reported as a risk factor leading to severe organ damage or death. In sharp contrast, some other studies revealed that triggering NK cell activity contributes to alleviating sepsis. In all, although there are several reports on NK cells in sepsis, whether they exert detrimental or protective effects remains unclear. Here, we will review the available experimental and clinical studies about the opposing roles of NK cells in sepsis, and we will discuss the prospects for NK cell-based immunotherapeutic strategies for sepsis.

Keywords: detrimental effect; immunotherapy; natural killer cells; protective effect; sepsis.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Immunity, Innate*
  • Killer Cells, Natural
  • Macrophages
  • Neutrophils / pathology
  • Sepsis*

Grants and funding

This study was supported by grants from Military Biosafety Program (19SWAQ18, to HL), National Defense Science and Technology Basic Enhancement Program (2021-JCJQ-JJ-1081, to HL), the Natural Science Foundation of Chongqing (cstc2020jcyj-msxmX0510, to FW), 2019 Army Medical Center Talent Innovation Program (2019CXJSC016, to FW) and the Doctor’s Through Train Project of Chongqing (CSTB2022BSXM-JCX0024, to FW).